Pharmaceutical Industry Articles & Reports - Page 2

Learn about Clinical Decision Support (CDS) systems, from early rule-based expert systems to modern data-driven models powered by artificial intelligence.

This article defines open-source LIMS and details its core functions, such as sample registration, data collection, quality control, and workflow management.

This article provides a comprehensive review of global Health Management Information Systems (HMIS), detailing their function, software types, and implementation.

An overview of the healthcare revenue cycle, a financial process covering all administrative and clinical functions from patient scheduling to payment collection.

An explanation of Clinical Data Management (CDM) and its function in research. Learn how CDM ensures high-quality, reliable data for clinical trials.

An overview of key researchers and industry leaders in the US applying generative AI models to pharmaceutical R&D, drug discovery, and biomarker research.

Learn about AHIP certification, the standard for Medicare agents. This guide explains the MFWA training, program requirements, costs, and its industry role.

An analysis of AI adoption trends in U.S. hospitals. Examines clinical and operational use cases, technology partnerships, and ethical considerations in healthcare.

Examines the top 10 programming languages by usage and popularity in the context of AI-assisted coding, analyzing AI tool support and ecosystem maturity.

An analysis of the 2025 healthcare administration job market. Examines key trends, demand drivers, worker shortages, and BLS employment projections.

An analysis of large language model (LLM) diagnostic performance on medical benchmarks compared to physicians, exploring accuracy, limitations, and implications.

Learn about mechanistic interpretability, a method to reverse-engineer AI models. This article explains how it uncovers causal mechanisms within neural networks.

An overview of pharmaceutical KPIs for quality, compliance, and operational excellence. Explores metrics for R&D, manufacturing, and regulatory standards.

An analysis of the core technologies and design philosophies of Wolfram Alpha (symbolic AI) and ChatGPT (generative AI), detailing their key differences.

This article explains how pill identifier software improves patient safety by accurately identifying medication using physical traits, preventing costly medical errors.

An educational profile of ZUSDURI, a mitomycin hydrogel for intravesical chemoablation of low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC).

An analysis of the Medicare program in 2025, detailing the structure and the significant policy impacts of the One Big Beautiful Bill Act (P.L. 119-21).

Examine 2025 trends for Contract Sales Organizations in pharma. This analysis compares top providers and strategies for HCP engagement and outsourcing.

This article explains how AI tools can validate regulatory dossiers, catch technical errors before submission, and minimize rework for emerging biotech companies.

Examines the evolution of eCTD systems from specialized publishers for regulatory submissions to enterprise platforms that serve as a unified drug lifecycle archive.

This article examines the unique financial challenges facing regional hospitals and details the accounting practices essential for maintaining stability and compliance.

An overview of San Francisco Bay Area neuroscience firms. Examines companies in neurotechnology, BCIs, and neuropharmacology, detailing their focus and status.

An overview of AI in pharmacovigilance, detailing its use in signal detection, case processing automation, and managing regulatory & ethical considerations.

An overview of market access analytics, covering its definition, scope, and role in helping pharmaceutical firms navigate complex payer reimbursement models.